Johnson & Johnson: Single-shot vaccine submitted for EU appr

Johnson & Johnson: Single-shot vaccine submitted for EU approval


Share this article
The Health Minister Stephen Donnelly says it is 'really welcome news' that a coronavirus vaccine being developed by Johnson & Johnson has been submitted for approval to the European Medicines Agency (EMA).
Ireland has an Advance Purchase Agreement for 2.2 million doses of the drug.
The EMA says it could make a decision on the single-shot vaccine by the middle of next month.
However, this is assuming the data relating to its efficacy, safety and quality are comprehensive and robust.
The Janssen drug has been shown to be 66% effective against COVID-19.
Johnson & Johnson is the parent company of Janssen, both of which have Irish operations.

Related Keywords

Ireland , France , Irish , Stephen Donnelly , Olivier Chassignole , Stephen Donnelly Donnellystephen , Luke Oneill , Tropical Medical Bureau , Astrazeneca , European Medicines Agency , European Commission , Johnson , Health Minister Stephen Donnelly , Advance Purchase Agreement , Newstalk Breakfast , Professor Lukeo Neill , Trinity Immunologist , Pat Kenny , ஐயர்ல்யாஂட் , பிரான்ஸ் , ஐரிஷ் , ஸ்டீபன் டோநிலீ , லூக் ஓனேிழில் , வெப்பமண்டல மருத்துவ பணியகம் , ஐரோப்பிய தரகு , ஜான்சன் , ஆரோக்கியம் அமைச்சர் ஸ்டீபன் டோநிலீ , திரித்துவம் நோயெதிர்ப்பு நிபுணர் , பேட் கெண்ணி ,

© 2025 Vimarsana